LIAISON PLEX Respiratory Flex Assay— 510(k) K233410

Name: FDA 510(k) clearance K233410
Creator: U.S. Food and Drug Administration
Published: 2024-03-01

Substantially Equivalent

Luminex Corporation

FDA 510(k) clearance K233410 for LIAISON PLEX Respiratory Flex Assay, Substantially Equivalent on 2024-03-01. Applicant: Luminex Corporation. Device class: 2.

Clearance details

Applicant: Luminex Corporation
Product code: Code QOF
Device class: Class 2
Regulation: 21 CFR 866.3981
Advisory panel: Microbiology
Date received: 2023-10-06
Decision date: 2024-03-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Northbrook, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code QOF

view all

K261837 — FINDER Flu A&B/SARS-CoV-2 Test2026-09-11
K252932 — Fast PCR Mini Respiratory Panel2026-06-12
K252269 — FINDER Flu A&B/SARS-CoV-2 Test2026-03-30
K251742 — VELO Respiratory Test2026-02-13
K251978 — LIAISON NES FLU A/B, RSV & COVID-192025-12-23

More clearances from Luminex Corporation

view all

K253722 — LIAISON PLEX Gastrointestinal Flex Assay2026-05-19
K243490 — LIAISON PLEX Gram-Positive Blood Culture Assay2025-06-06
K243013 — LIAISON PLEX Gram-Negative Blood Culture Assay2025-04-18
K240627 — LIAISON PLEX Yeast Blood Culture Assay2024-06-04
K191742 — ARIES MRSA Assay2019-09-25

Data sourced from openFDA. This site is unofficial and independent of the FDA.